FDA-Inspected Site

Ladd Family Pharmacy LLC

2 FDA inspections are on record for Ladd Family Pharmacy LLC in Boise, United States.

483· Form 483 issued

Boise, United States · Last updated July 10, 2026

Overview

  • 2 FDA inspections are on record.
  • 2 inspections produced a Form 483.
  • The most recent recorded inspection date is 2019-07-30.

At a glance

Inspections

2

Form 483s

2

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
22 Jul 2019 – 30 Jul 2019Human Drugs483View 483 →
12 Sep 2016 – 23 Sep 2016Human DrugsWLView 483 →

Observations on record

Form 483 observations cited at this site, most recent first.

30 Jul 2019
FDCA 501(a)(2)(A)

Hazardous drugs, prevention of cross-contamination

Cited by Joshua P Wireman

30 Jul 2019
FDCA 501(a)(2)(A)

Use of non-pharmaceutical grade components

Cited by Joshua P Wireman

23 Sep 2016
21 CFR 211.160(b)(3)

Acceptance of drug products

Cited by Christopher R Czajka, Nancy E Byerly

23 Sep 2016
21 CFR 211.166(a)

Lack of written stability program

Cited by Christopher R Czajka, Nancy E Byerly

23 Sep 2016
21 CFR 211.42(c)

Defined areas of adequate size for operations

Cited by Christopher R Czajka, Nancy E Byerly

Investigators

FDA investigators tied to this site in the record.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
FDCA 501(a)(2)(A)Cited across public-safe Form 483 observations2x
21 CFR 211.160(b)(3)Cited across public-safe Form 483 observations1x
21 CFR 211.166(a)Cited across public-safe Form 483 observations1x
21 CFR 211.42(c)Cited across public-safe Form 483 observations1x
21 CFR 211.67(a)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Ladd Family Pharmacy LLC's 2 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat